Harrow HROW
NASDAQ HROW
$41.39 -0.25 (-0.60%)
At close: Aug 20, 2026 · 1:45 PM UTC

Harrow (HROW) FCF Margin (2013 - 2026)

Harrow (HROW) posted quarterly FCF Margin of 20.78% for Q1 2026, down 6155.0% year-over-year from 0.34% in Q1 2025, and down 329.42% quarter-over-quarter from 9.06% in Q4 2025.

Harrow (HROW) FCF Margin (2013 - 2026) Analysis & Trends

Harrow's FCF Margin history runs 14 years deep, the most recent figure standing at 20.78% for Q1 2026.

  • In Q1 2026, FCF Margin fell 6155.0% year-over-year to 20.78%; the TTM figure through Mar 2026 stood at 5.32% (up 512.0% YoY), while the FY2025 annual figure was 15.78%, up 2770.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 20.78%, down from 9.06% in the prior quarter.
  • The five-year high for FCF Margin was 40.76% in Q1 2025, with the low at 33.37% in Q1 2023.
  • The 5-year median for FCF Margin is 1.2% (2025), against an average of 0.03%.
  • The sharpest annual moves came in 2025 and 2026: FCF Margin jumped 5440 bps in 2025, then tumbled 6155 bps in 2026.
  • Harrow's FCF Margin stood at 22.58% in 2022, then soared by 204 bps to 23.39% in 2023, then plunged by 223 bps to 28.72% in 2024, then jumped by 132 bps to 9.06% in 2025, then sank by 329 bps to 20.78% in 2026.
  • Business Quant data shows HROW's FCF Margin at 20.78% in Q1 2026, 9.06% in Q4 2025, and 22.57% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn 7.41%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 21.80%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 14.87%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 26.25%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn 8.76%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 13.41%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 17.84%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Harrow 1.55 Bn 1.46 Bn 50.36 Mn -14.50%

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.50%
Mar 31, 2026 -20.78%
Dec 31, 2025 9.06%
Sep 30, 2025 22.57%
Jun 30, 2025 -1.20%
Mar 31, 2025 40.76%
Dec 31, 2024 -28.72%
Sep 30, 2024 5.72%
Jun 30, 2024 -5.52%
Mar 31, 2024 -13.64%
Dec 31, 2023 23.39%
Sep 30, 2023 -6.88%
Jun 30, 2023 14.78%
Mar 31, 2023 -33.37%
Dec 31, 2022 -22.58%
Sep 30, 2022 -6.42%
Jun 30, 2022 19.72%
Mar 31, 2022 2.55%
Dec 31, 2021 -8.06%
Sep 30, 2021 -12.64%